Pharma supply chains

AI at heart of Roche’s future strategy

This content was published on Sep 28, 2026 Swiss pharmaceutical giant Roche outlined its ambitious future plans, which include greater use of artificial intelligence to speed up research and development discovery, at ‌its pharma investor day on Monday.

National Council rejects the Medicines Supply Initiative

Swiss democracy

Swiss lawmakers reject medicines security initiative

This content was published on Sep 24, 2026 Swiss parliamentary chamber adopts government counter-proposdal to medicine initiative.

Strong growth confirmed in the second quarter in Switzerland

Workplace

Swiss economy posts strong growth in second quarter

This content was published on Sep 3, 2026 The Swiss economy grew by 1.5% in the second quarter of the year compared with the previous quarter, SECO said on Thursday.

Pharma supply chains

Is there still a future for vitamin production in Switzerland?

This content was published on Sep 3, 2026 China dominates global vitamin production, creating challenges for European players and future supply.

Novartis is cutting up to 130 jobs in Basel

Pharma supply chains

Novartis to cut up to 130 jobs in Basel

This content was published on Sep 2, 2026 Novartis plans to cut up to 130 Basel jobs as biologics work shifts to other sites and its campus.

Pharma supply chains

Novartis halts clinical trials following patient deaths

This content was published on Sep 1, 2026 At the end of August, Novartis halted several clinical trials of experimental cell therapies for autoimmune diseases in the fields of immunology and neuroscience, following the deaths of three patients.

Pharma supply chains

Swiss exports rebounded in July driven by pharma sector

This content was published on Aug 20, 2026 Switzerland’s foreign trade rebounded in July, with exports showing strong growth following a decline the previous month.

Sandoz is expanding its generic medicines business

Pharma supply chains

Sandoz expands biosimilars business with Chinese biotech deal

This content was published on Aug 17, 2026 Sandoz has signed a multi-million-dollar agreement with Chinese biotech company Shanghai Henlius Biotech, stepping up its expansion in biosimilars, the generic versions of complex biological medicines.

Healthcare innovation

What’s behind the peptide boom and why it matters to Switzerland

This content was published on Aug 3, 2026 Peptides are in growing demand for everything from weight loss to rare cancers. This is good news for Swiss peptide makers.

Sandoz "takes note" of the new US tariffs

Pharma supply chains

Swiss pharma firm Sandoz takes note of proposed US tariffs on generic drugs

This content was published on Jul 22, 2026 Generic drugs giant Sandoz said on Wednesday that it had “taken note” of Washington’s announcements regarding new tariffs of up to 200%.

Pharma supply chains

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Pharma supply chains

More

AI at heart of Roche’s future strategy

More

Swiss lawmakers reject medicines security initiative

More

Swiss economy posts strong growth in second quarter

More

Is there still a future for vitamin production in Switzerland?

More

Novartis to cut up to 130 jobs in Basel

More

Novartis halts clinical trials following patient deaths

More

Swiss exports rebounded in July driven by pharma sector

More

Sandoz expands biosimilars business with Chinese biotech deal

More

What’s behind the peptide boom and why it matters to Switzerland

More

Swiss pharma firm Sandoz takes note of proposed US tariffs on generic drugs

Popular Stories

Most Discussed